Supplements

vhip easl supplement

Viral hepatitis in prctice – Daklinza®▼(daclatasvir): up to the challenge of genotype 3

May 2016, Sponsored Supplement

 

 
vhip easl supplement

Viral hepatitis: current options, future directions – a report from the International Liver Congress 2015

August 2015, Sponsored Supplement

 

 
Daklinza® (daclatasvir):the first approved NS5A inhibitor in the UK for the treatment of hepatitis C

Daklinza® (daclatasvir):the first approved NS5A inhibitor in the UK for the treatment of hepatitis C

February 2015, Sponsored Supplement

 

 

Treating hepatitis C – the cost of waiting, the value of action

Winter 2014, Sponsored Supplement

 

 

 

Hepatitis C: the new era of management – a report from the International Liver Congress 2014

July 2014, Volume 6 Number 1, Sponsored Supplement

 

 

 
Hepatitis C in the UK: A real-world perspective

Hepatitis C in the UK: A real-world perspective

Spring 2014, Sponsored Supplement
Prescribing information can be found on the back page of the supplement.
 

 
Hepatitis C – a report from the European Association for the Study of the Liver 2013 annual meeting

Hepatitis C – a report from the European Association for the Study of the Liver 2013 annual meeting

November 2013, Volume 5 Number 2, Sponsored Supplement
 

 

Information for advertisers/sponsors
To find out more about supplement opportunities or request a copy of our supplement guidelines, contact Kirsty Haves at:

Viral hepatitis in practice was previously supported by Gilead Sciences from 2015 to 2016, by Gilead Sciences and Janssen in 2014, by Gilead Sciences and Roche Products in 2013 and by Gilead Sciences from 2009 to 2012.


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsor, publisher, Editor or Editorial Board. Accordingly the sponsor, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Viral hepatitis in practice is the property of Hayward Group Ltd and, together with the content, is bound by copyright. Copyright © 2017 Hayward Group Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 2041-1162 (Print)  ISSN 2045-7863 (Online)